Literature DB >> 25915884

Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.

Richard D Semba1, Kai Sun, Ann V Schwartz, Ravi Varadhan, Tamara B Harris, Suzanne Satterfield, Melissa Garcia, Luigi Ferrucci, Anne B Newman.   

Abstract

OBJECTIVE: The objective of this study is to examine the relationship of serum carboxymethyl-lysine (CML), an advanced glycation end product (AGE), with pulse pressure (PP), aortic pulse wave velocity (aPWV) and hypertension in older adults.
BACKGROUND: AGEs are bioactive molecules that accumulate in tissues with ageing and can both cross-link collagen and induce inflammation in model systems. The relationship of AGEs with arterial stiffness and hypertension has not been well characterized in community-dwelling older adults.
METHODS: We measured serum CML and blood pressure in 3044 adults, aged 70-79 years, who participated in the Health, Aging and Body Composition Study, a population-based study of ageing in Pittsburgh, Pennsylvania and Memphis, Tennessee. aPWV was measured in 2468 participants.
RESULTS: Participants in the highest tertile of serum CML had higher PP (highest tertile: beta = 2.85, SE = 0.82, P = 0.0005; middle tertile: beta = 0.60, SE = 0.80, P = 0.45), and higher aPWV (highest tertile: beta = 51.4, SE = 20.1, P = 0.01; middle tertile: beta = 3.2, SE = 19.8, P = 0.87) than those in the lowest tertile in multivariable linear regression models adjusting for age, sex, race, education, BMI, smoking, alcohol use, total cholesterol, high-density lipoprotein (HDL) cholesterol, diabetes, cardiovascular disease and chronic kidney disease. Participants in the highest and middle tertiles of serum CML had higher odds of hypertension [odds ratio (OR) 1.32, 95% confidence interval (95% CI) 1.06-1.60, P = 0.005; OR 1.27, 95% CI 1.05-1.53, P = 0.01, respectively] than those in the lowest tertile in a multivariable logistic regression model adjusting for the same covariates.
CONCLUSION: Elevated serum CML was associated with arterial stiffness, as reflected by higher PP and aPWV, in older, community-dwelling adults.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25915884      PMCID: PMC4458067          DOI: 10.1097/HJH.0000000000000460

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  49 in total

Review 1.  Ageing of the conduit arteries.

Authors:  S E Greenwald
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Long-term variability of inflammatory markers and associated factors in a population-based cohort.

Authors:  Scott D Nash; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; F Javier Nieto; Rick Chappell; Carla R Schubert; Michael Y Tsai
Journal:  J Am Geriatr Soc       Date:  2013-07-26       Impact factor: 5.562

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Authors:  Kathryn C B Tan; Wing-Sun Chow; Victor H G Ai; Christine Metz; Richard Bucala; Karen S L Lam
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

5.  Association of serum lipids with arterial stiffness in a population-based study in Beijing.

Authors:  Fan Wang; Ping Ye; Leiming Luo; Wenkai Xiao; Liping Qi; Suyan Bian; Hongmei Wu; Li Sheng; Tiehui Xiao; Ruyi Xu
Journal:  Eur J Clin Invest       Date:  2011-02-14       Impact factor: 4.686

6.  Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.

Authors:  Miranda T Schram; Casper G Schalkwijk; Aart H Bootsma; John H Fuller; Nish Chaturvedi; Coen D A Stehouwer
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

7.  Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Authors:  B K Kilhovd; T J Berg; K I Birkeland; P Thorsby; K F Hanssen
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.

Authors:  Xiaohong Zhang; Matthias Frischmann; Rose Kientsch-Engel; Katharina Steinmann; Helga Stopper; Toshimitsu Niwa; Monika Pischetsrieder
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

9.  Tobacco smoke is a source of toxic reactive glycation products.

Authors:  C Cerami; H Founds; I Nicholl; T Mitsuhashi; D Giordano; S Vanpatten; A Lee; Y Al-Abed; H Vlassara; R Bucala; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

10.  Relations of arterial stiffness and endothelial function to brain aging in the community.

Authors:  Connie W Tsao; Sudha Seshadri; Alexa S Beiser; Andrew J Westwood; Charles Decarli; Rhoda Au; Jayandra J Himali; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Martin G Larson; Emelia J Benjamin; Philip A Wolf; Ramachandran S Vasan; Gary F Mitchell
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

View more
  21 in total

1.  Serum and Urine Thioflavin-T-Enhanced Fluorescence in Severe Preeclampsia.

Authors:  Katherine R Millen; Catalin S Buhimschi; Guomao Zhao; Kara M Rood; Sammy Tabbah; Irina A Buhimschi
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

2.  Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.

Authors:  Stephanie J Loomis; Yuan Chen; David B Sacks; Eric S Christenson; Robert H Christenson; Casey M Rebholz; Elizabeth Selvin
Journal:  Clin Chem       Date:  2017-03-09       Impact factor: 8.327

3.  Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects.

Authors:  Diego Gomes Kjerulf; Shari Wang; Mohamed Omer; Asha Pathak; Savitha Subramanian; Chang Yeop Han; Chongren Tang; Laura J den Hartigh; Baohai Shao; Alan Chait
Journal:  J Diabetes Complications       Date:  2020-07-31       Impact factor: 2.852

4.  Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.

Authors:  V C Luft; B B Duncan; M I Schmidt; L E Chambless; J S Pankow; R C Hoogeveen; D J Couper; G Heiss
Journal:  Diabet Med       Date:  2015-10-06       Impact factor: 4.359

5.  Identification of urinary metabolites with potential blood pressure-lowering effects in lentil-fed spontaneously hypertensive rats.

Authors:  Matthew Hanson; Peter Zahradka; Carla G Taylor; Michel Aliani
Journal:  Eur J Nutr       Date:  2016-10-21       Impact factor: 5.614

Review 6.  Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?

Authors:  Kailash Prasad; Manish Mishra
Journal:  Int J Angiol       Date:  2017-02-03

7.  Biocatalytic Reversal of Advanced Glycation End Product Modification.

Authors:  Nam Y Kim; Tyler N Goddard; Seungjung Sohn; David A Spiegel; Jason M Crawford
Journal:  Chembiochem       Date:  2019-08-09       Impact factor: 3.164

Review 8.  Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging.

Authors:  Mingyi Wang; Robert E Monticone; Kimberly R McGraw
Journal:  J Vasc Res       Date:  2018-08-02       Impact factor: 1.934

Review 9.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

10.  Epidemiology, pathophysiology, and prognosis of heart failure in the elderly.

Authors:  Sabu Thomas; Michael W Rich
Journal:  Heart Fail Clin       Date:  2007-10       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.